Small supernumerary marker chromosome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Small supernumerary marker chromosome | |
|---|---|
| File:MarkerChromosomeG-Banding-BMC-Cancer-2006-6-Fig2a.jpg | |
| Synonyms | sSMC |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Variable, depending on the specific genetic material involved |
| Complications | Developmental delay, congenital anomalies, infertility |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Chromosomal abnormality |
| Risks | Genetic predisposition |
| Diagnosis | Karyotype analysis, FISH, array CGH |
| Differential diagnosis | Other chromosomal abnormalities |
| Prevention | N/A |
| Treatment | Symptomatic and supportive |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | 0.043% of the general population |
| Deaths | N/A |
Small Supernumerary Marker Chromosome (sSMC) is a chromosomal abnormality characterized by the presence of an additional marker chromosome that is too small to be easily characterized by standard cytogenetic methods. sSMCs are structurally abnormal chromosomes that can originate from any of the 24 human chromosomes and are typically less than 5 megabases in size. Their clinical significance varies widely, ranging from being phenotypically neutral to being associated with various congenital anomalies and developmental delays, depending on factors such as the genetic content of the sSMC and whether it results in a net gain of genetic material.
Etiology[edit]
sSMCs can arise de novo or can be inherited from a parent. The formation of sSMCs is often associated with aberrant chromosomal replication or segregation during meiosis or mitosis. This can lead to the generation of extra chromosomal fragments that may form a marker chromosome. The specific origin of an sSMC can sometimes be determined using advanced cytogenetic techniques, such as fluorescence in situ hybridization (FISH) or array comparative genomic hybridization (aCGH).
Clinical Significance[edit]
The impact of an sSMC on an individual's development and health is highly variable. Some individuals with an sSMC exhibit no apparent phenotypic effects, while others may experience a range of clinical manifestations, including intellectual disability, developmental delays, congenital malformations, and infertility. The phenotypic outcomes are influenced by several factors, including the genetic content of the sSMC, whether it is euchromatic or heterochromatic, and its mosaicism level within the individual's cells.
Diagnosis[edit]
Diagnosis of sSMC typically involves cytogenetic analysis to detect the presence of the marker chromosome. Techniques such as karyotyping, FISH, and aCGH are commonly used to characterize the sSMC in terms of its size, structure, and chromosomal origin. Prenatal diagnosis of sSMC is possible through amniocentesis or chorionic villus sampling (CVS) followed by cytogenetic analysis.
Management[edit]
Management of individuals with an sSMC is tailored to the specific needs of the individual and is based on the clinical manifestations associated with the sSMC. This may include developmental interventions, educational support, and medical management of any associated congenital anomalies or health issues. Genetic counseling is recommended for individuals with an sSMC and their families to discuss the potential for inheritance and recurrence risk in future pregnancies.
Research Directions[edit]
Research on sSMCs is focused on better understanding their formation, the range of phenotypic outcomes associated with different types of sSMCs, and the development of more precise diagnostic and prognostic tools. Advances in genomic technologies, such as next-generation sequencing, are improving the ability to characterize the genetic content of sSMCs and to identify the genes that contribute to the clinical manifestations associated with these chromosomal abnormalities.
A chromosome and its packaged long strand of DNA unraveled. The DNA's base pairs encode genes, which provide functions. A human DNA can have up to 500 million base pairs with thousands of genes.
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian